TRIM25 and breast carcinoma: Mechanistically, TRIM25-associated drug resistance was linked with downregulation of the scaffold protein 14-3-3σ (Figure 2), which itself is a known target of TRIM25-dependent proteasomal degradation in breast cancer by depending on the ubiquitin conjugating enzyme UbcH8 [54].